These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 4577471

  • 21. Amantadine in extrapyramidal syndromes induced by neuroleptic drugs.
    Dencker SJ, Lindberg D, Malm U.
    Nord Psykiatr Tidsskr; 1973; 27(1):31-4. PubMed ID: 4687749
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Akathisia: a side effect to be remembered.
    Raskin DE.
    Am J Psychiatry; 1972 Sep; 129(3):345-7. PubMed ID: 5053718
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ, Cazzullo CL, Cocchi A, Denber HC, Freyhan FA, Klerman GL, Köknel O, Levine J, Saarma J, Sarteschi P, Vinar O, Wittenborn JR.
    Mod Probl Pharmacopsychiatry; 1970 Sep; 5():148-56. PubMed ID: 4949818
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E, Christodoulides H.
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.
    Rubovits R, Klawans HL.
    Arch Gen Psychiatry; 1972 Oct; 27(4):502-7. PubMed ID: 5072718
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome.
    Jus K, Jus A, Gautier J, Villeneuve A, Pires P, Pineau R, Villeneuv R.
    Int J Clin Pharmacol; 1974 Mar; 9(2):138-45. PubMed ID: 4827556
    [No Abstract] [Full Text] [Related]

  • 35. Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
    Klawans HL, Rubovits R.
    J Neurol Neurosurg Psychiatry; 1974 Aug; 37(8):941-7. PubMed ID: 4418481
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
    Dom R, Van Lommel R, Baro F.
    Acta Psychiatr Scand; 1971 Aug; 47(4):399-410. PubMed ID: 4947805
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.